Follow Us TR

News Details

VistaGen Expands PH94B Clinical Development to Include Adjustment Disorder Related to COVID-19

About VistaGen Therapeutics, Inc.
  • NASDAQ: $VTGN
  • Notified: $0.65
  • 09:17 EDT

Price Chart